[ESPR] YoY Quarter Result on 30-Sep-2003 [#Q3]

Stock
[ESPR] Esperion Therapeutics, Inc.
Announcement Date
29-Sep-2003
Financial Year
2003
Quarter
30-Sep-2003 [#Q3]
Profit Trend
QoQ- 22.19%
YoY- 5.97%
Quarter Report
ESPR's Result
ESPR's Financial Summary
View:
Show?
Quarter Result
30/09/14 30/09/13 30/09/12 30/09/03 30/09/02 30/09/01 30/09/00 CAGR
Revenue 0 0 0 0 0 0 1 -
PBT -9,806 -5,238 -3,351 -6,563 -6,980 -6,281 -11,693 -1.24%
Tax 164 168 362 578 177 736 3,556 -19.71%
NP -9,806 -5,238 -3,351 -6,563 -6,980 -6,281 -10,804 -0.68%
Tax Rate - - - - - - - -
Total Cost 9,806 5,238 3,351 6,563 6,980 6,281 10,805 -0.69%
Ratio Analysis
30/09/14 30/09/13 30/09/12 30/09/03 30/09/02 30/09/01 30/09/00 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 -1,080,400.00 -
Per Share
30/09/14 30/09/13 30/09/12 30/09/03 30/09/02 30/09/01 30/09/00 CAGR
EPS -0.64 -0.34 -0.35 -1.42 -1.67 -1.56 -5.14 -13.81%
EPS Diluted -0.64 -0.34 -0.35 -1.42 -1.67 -1.56 -5.14 -13.81%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.